Home » Newsletters » BioWorld Science

BioWorld Science

March 5, 2015

View Archived Issues

Cerulean collaborates with GOG Foundation to study CRLX-101 with paclitaxel in ovarian cancer

ISA and Shin Nippon Biomedical to investigate nasal delivery of HPV16 vaccine

Addition of ipilimumab to Prostvac appears beneficial in treating prostate cancer

BMS gains option to license Prostvac from Bavarian Nordic

CTX conditioning maximizes SB-728-T engraftment

Encouraging results seen with TRC-105 and axitinib in renal cell carcinoma trial

Innocrin Pharmaceuticals presents encouraging data for VT-464

Durect highlights epigenomic regulator program and completion of phase I trial

Islet Sciences signs license agreement with Brighthaven Ventures for remogliflozin

Array BioPharma forms agreement with Novartis for binimetinib and encorafenib

Boston Scientific to acquire American Medical Systems' urology portfolio

Daktari closes series D funding round to support diagnostic platform

IlluminOss Medical enrolls first patient in humerus fracture repair trial

Loxo Oncology provides update on selected pipeline programs

NICE publishes guideline recommending photodynamic diagnosis to improve detection of bladder cancer

Novartis patents new MEK inhibitors

German researchers disclose glutathione peroxidase inhibitors

KU Leuven patents new antibiotics

Sun Pharma to buy GlaxoSmithKline's opiates business in Australia

Roche discloses RSV fusion inhibitors

Novogen's TRXE-009 shows potential for adult and pediatric brain cancer

First-in-human MesomiR 1 study results confirm tolerability of TargomiRs

RQx Pharmaceuticals reports new peptide antibiotics

AbbVie to acquire Pharmacyclics

FDA approves Opdivo for metastatic squamous NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...